Medlive Tech, Brii Bio hit Hong Kong IPO market
Medlive Technology and Brii Biosciences are tapping investors for a combined HK$6.7bn ($863m).
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: